Figure 5

![Figure 5: Experimental evidence from animal models of neuroimmune disorders showing the effects of specific CAM therapies on Th17 cell frequency and disease severity scores.]()

> Source: Aristo Vojdani et al. "The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.." *Evidence-based complementary and alternative medicine : eCAM*, 2011. PMID: [19622601](https://pubmed.ncbi.nlm.nih.gov/19622601/)

<figure>
  <img src="" alt="Experimental evidence from animal models of neuroimmune disorders showing the effects of specific CAM therapies on Th17 cell frequency and disease severity scores." />
  <figcaption>Figure 5. Experimental evidence from animal models of neuroimmune disorders showing the effects of specific CAM therapies on Th17 cell frequency and disease severity scores.<br>  Source: Aristo Vojdani et al. "The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.." <em>Evidence-based complementary and alternative medicine : eCAM</em>, 2011. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/19622601/">19622601</a></figcaption>
</figure>